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In	 our	 study,	 we	 investigated	 the	 effects	 of	 intra­CA1	 microinjections	 of	 a	 selective	 b1­
adrenoreceptor	 antagonist,	 betaxolol,	 on	 state­dependent	memory	 induced	 by	morphine.	A	
step­through	passive	avoidance	task	was	used	to	assess	memory	retrieval.	Male	Wistar	rats	
were	bilaterally	implanted	with	chronic	cannulas	in	the	CA1 regions of the dorsal hippocampus 
by	stereotaxic	surgery	seven	days	before	training.	Each	animal	was	tested	24	h	after	training	
to	measure	the	step­through	latency	and	the	time	spent	in	a	dark	chamber	of	the	apparatus.	
Post-training intra-CA1	administrations	of	different	doses	of	morphine	(5	and	7.5	mg/kg,	s.c.)	
decreased	memory	retrieval	in	the	retention	test	(morphine­induced	amnesia).	The	effect	of	
post­training	injections	of	7.5	mg/kg	morphine	on	retrieval	was	reversed	by	pre­test	injection	
of	the	same	dose	of	morphine.	This	phenomenon	is	named	morphine	state­dependent	memory.	
The results also showed that pre-test intra-CA1	microinjection	 of	 ineffective	 low	doses	 of	
betaxolol	 (0.125	 and	 0.25	 mg/rat)	 inhibited	 morphine­induced	 state­dependent	 memory	
retrieval.	 Taken	 together,	 our	 results	 suggest	 that	 the	CA1	 may	 be	 potentially	 critical	 for	
morphine	 state­dependent	 memory,	 and	 the	 b1­adrenergic	 receptor	 mechanism(s)	 interact	
with the opioidergic system in the modulation of this type of memory in the CA1.
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INTRODUCTION
State­dependent	 learning	 is	 a	 model	 for	 studying	
memory	 retrieval.	 This	 type	 of	 memory	 exists	 when	
experimental animals are in the same physiological 
state	during	both	 the	acquisition	and	 retrieval	phases	
of	 memory	 [1].	 State­dependent	 memory	 has	 been	
demonstrated	using	some	drugs,	such	as	morphine	and	
other	 opioidergic	 agents	 [2,	 3].	 The	measurement	 of	
the	 step­through	 latency	 in	 an	 inhibitory	 avoidance	
task	 has	 been	 used	 in	 pharmacological	 studies	 of	
memory	 in	 experimental	 animals.	 It	 is	 well	 known	
that	the	impairment	effect	of	morphine	is	reversed	by	
pretest administration of the same doses of morphine 
in	an	inhibitory	avoidance	model	of	memory	[2,	4,	5].
We	 demonstrated	 earlier	 that	 post­training	
administration of morphine can impair retrieval in 
the	 inhibitory	 avoidance	 memory	 tests,	 and	 this	 is	
reversible	 by	 pre­test	 administration	 of	 morphine;	
the	 respective	 effect	 can	 be	 named	 morphine	 state­
dependent	memory	retrieval	[6,	7].	Morphine­induced	
amnesia	[8]	and	morphine	state­dependent	memory	[9]	
are	 antagonized	by	 injections	of	naloxone;	 therefore,	
it seems that µ-opioid receptors mediate this effect 
of	morphine	on	memory	retrieval.	It	seems	that	 these	
effects	of	morphine	on	memory	processes	may	be	due	to	
interaction	 between	 central	 neurotransmitter	 systems	
in	different	regions	of	the	brain,	such	as	glutamatergic	
[10],	cholinergic	[11,	6],	and	noradrenergic	[12].
Vast	 neuropharmacological	 studies	 clearly	
demonstrated	 a	 major	 role	 of	 norepinephrine	 in	 the	
regulation	of	cognitive	 functions;	 this	 is	provided	by	
interaction	 with	 two	 classes	 of	 adrenergic	 receptors,	
a and b.	 Although	 brain	 b-adrenergic receptors are 
substantially	 less	 numerous	 than	 a­receptors,	 they	
are	 crucial	 for	 memory	 formation.	 Noradrenergic	
neurons	 localized	 in	 the	 brainstem	 have	 widespread	
projections	 throughout	 different	 brain	 regions	 [13],	
including	 the	 neocortex	 and	 hippocampus	 [14,	 15].	
It	 was	 shown	 that	 microinjections	 of	 an	 adrenergic	
agent,	 such	 as	 norepinephrine,	 into	 the	 hippocampus	
potentiate	memory	formation	[16].		
Different studies using adrenergic agonists and 
antagonists demonstrated that central b-adrenergic 
receptors play an important role in memory formation 
[17­19].	Blocking	of	these	receptors	impairs	different	
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phases	 of	 the	memory	 processes,	 namely	 acquisition	
[20,	21],	consolidation	[22,	23],	retrieval	[24,	25],	and	
reconsolidation	[18,	26].	All	subtypes	of	b-adrenergic 
receptors	 (b1,	 b2,	 and	 b3)	 have	 been	 found	 in	
mammalian	 brain	 regions	 [27].	 These	 receptors,	 by	
coupling	to	G	proteins,	activate	adenylate	cyclase	and	
an	 intracellular	 cAMP­PKA­MAPK­CREB	 signaling	
pathway	that	is	necessary	for	memory	formation	[28].
The	 hippocampus,	 a	 part	 of	 the	 medial	 temporal	
structures,	 plays	 a	 central	 and	 critical	 role	 in	 the	
formation	 of	 memory	 [29].	 It	 is	 well	 known	 that	
b-adrenergic receptors in the CA1	 area,	 an	 important	
region	of	the	hippocampus,	are	involved	in	the	retrieval	
phase	 of	 several	 models	 of	 memory.	 Activation	 of	
b-adrenergic receptors in this area increases memory 
retrieval	[28,	30].	Furthermore,	b1­adrenergic	[31,	32]	
and	 opioid	 [33]	 receptors	 are	 extensively	 expressed	
in the CA1.	 There	 are	 behavioral	 investigations	
indicating that opioidergic and adrenergic mechanisms 
are	involved	in	memory	formation	[34,	35].	Based	on	
these	findings,	we	tried	in	our	study	to	determine	the	
possible	 involvement	 of	 b1­adrenergic	 receptors	 of	
the CA1 area in morphine-modified state-dependent 
memory in rats using a step-through passive avoidance 
model.
METHODS
Animals, Surgery and Drug Administration. Adult	
male	Wistar	 rats	 weighing	 200­250	 g	 at	 the	 time	 of	
surgery	 were	 used	 in	 this	 study.	 The	 animals	 were	
housed	 four	 per	 Plexiglas	 cage,	 with	 free	 access	 to	
water and food ad libitum,	 and	 kept	 at	 controlled	
temperature	(23	±	2°C)	under	a	12/12	h	light­dark	cycle	
(light	 beginning	 at	 7:00	 a.m.).	All	 experiments	were	
carried	 out	 during	 the	 light	 phase	 (between	9:00	 and	
14:00).	 Each	 experimental	 group	 consisted	 of	 seven	
animals.	 Procedures	 were	 performed	 in	 accordance	
with	 the	 National	Academy	 Guide	 for	 the	 Care	 and	
Use	of	Animals	in	Research.
Seven	 days	 before	 the	 beginning	 of	 behavioral	
experiments,	 the	 animals	 were	 anesthesized	 by	 i.p.	
administration	of	ketamine	hydrochloride	(50	mg/kg)	 
and	 xylazine	 (4	 mg/kg)	 and	 cannulated	 using	 a	
stereotaxic	 instrument	 (Stoelting,	 USA).	 Two	 guide	
cannulas	 (22­gauge,	 10	 mm	 long)	 were	 positioned	
bilaterally	 1	mm	above	 the	 region	of	 injection	based	
on the stereotaxic coordinates of the CA1 in the dorsal 
hippocampus,	 in	 accordance	 with	 the	 rat	 brain	 atlas	
(–3	mm	anterior	 to	 the	bregma,	±2	mm	 lateral	 to	 the	
sagittal	 suture,	 and	 2.8	mm	 ventral	 from	 the	 surface	
of	the	skull)	[36].	The	cannulas	were	anchored	to	the	
skull	with	dental	cement.	
The	 drugs	 (morphine	 sulfate,	 Temad,	 Iran,	 and	
betaxolol,	 Sinadarou,	 Iran)	 were	 dissolved	 in	 sterile	
saline.	 Morphine	 was	 administrated	 subcutaneously	
(s.c.),	while	betaxolol	was	microinjected	into	the	CA1 
by	 a	 Hamilton	 syringe	 and	 a	 needle	 (27­gauge,	 14	
mm	long)	joined	together	by	a	polyethylene	tube.	The	
latter	 solution	was	 infused	 in	 a	 volume	of	 0.5	µl	 per	
side	 (1	µl/rat)	within	 a	period	of	120	 sec,	 to	provide	
free	diffusion	of	the	drug	in	the	injected	region.
Behavioral Procedures. A	 step­through	 apparatus	
was	 used	 to	 evaluate	 inhibitory	 avoidance	 memory	
retrieval.	This	apparatus	consisted	of	two	(illuminated/
dark)	 compartments	 (each	 20×20×30	 cm)	 connected	
via	 a	 small	 door	 (7×9	 cm).	 The	 floor	 of	 the	 dark	
compartment	 was	 equipped	 with	 stainless	 steel	 rods	
(2.5	mm	in	diameter,	with	10­mm	intervals).	Electrical	
AC	shocks	(50	Hz,	1	mA,	3	sec)	could	be	delivered	to	
these	rods	by	an	isolated	stimulator.
Behavioral	procedures	included	two	phases,	training	
and	testing	(with	1­day­long	interval),	as	described	in	
our	pervious	study	[6].
On	 the	 training	 day,	 each	 rat	 was	 placed	 in	 the	
illuminated	 compartment;	 10	 sec	 later,	 the	 door	 was	
opened.	 Immediately	 after	 the	 animal	 entered	 the	 dark	
compartment,	 the	 door	 was	 closed,	 and	 the	 rat	 was	
transferred	to	the	home	cage.	The	latency	of	entering	the	
dark	 compartment	 (step­through	 latency,	 STL)	 and	 the	
time	spent	 in	 the	 latter	 (TSD)	were	measured.	Animals	
with	STLs	longer	than	100	sec	were	excluded	from	the	
research.
Each animal was placed again in the illuminated 
compartment	30	min	later.	Then	the	door	was	opened	
after	 10	 sec.	As	 soon	 as	 the	 animal	 entered	 the	 dark	
compartment,	and	all	four	paws	had	been	placed	on	the	
grid	 floor,	 the	door	was	 closed,	 and	 an	 electrical	AC	
shock	was	immediately	delivered	to	this	chamber.	The	
rat was temporarily transferred from the apparatus to 
its	home	cage	about	20	sec	after	receiving	the	shock.	
Two	min	 later,	 the	 rat	 again	 was	 placed	 in	 the	 light	
compartment	 (as	 in	 the	 prior	 trials).	 If	 the	 STL	 was	
longer	 than	 120	 sec,	 the	 acquisition	 stage	 of	 passive	
avoidance	memory	was	 successfully	 completed.	This	
procedure was repeated for animals that had not 
completed	the	test	successfully	(each	animal	received	
electrical	shocks	not	more	than	three	times).	
Long-term memory retrieval of animals was 
tested	24	h	after	training.	The	rats	were	placed	in	the	
illuminated	 chamber,	 and,	 after	 10	 sec,	 the	 door	was	
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opened.	 Without	 using	 electrical	 shocks	 during	 this	
phase,	 the	STLs	 and	TSD	were	 recorded	 for	 300	 sec	
for	assessment	of	memory	retrieval.
Experiments. Each animal received post-training 
administration	 of	 either	 saline	 or	 morphine	 s.c.,	 as	
reported	in	our	previous	communication	[6].	The	rats	
also received pretesting intra-CA1	 microinjections	
of	 saline,	 or	 betaxolol	 +	morphine,	 or	 saline	 s.c.	All	
animal	 groups	 (each	 group	 included	 eight	 rats)	were	
subjected	to	three	experiments.	
Experiment 1.	The	effects	of	post­training	and	pre­
test	 injections	 of	morphine	 on	 retrieval	 of	 inhibitory	
avoidance	memory	were	evaluated	in	this	experiment.	
Five	 animal	 groups	 (controls)	 received	 post­training	
administrations	 of	 saline	 (1	ml/kg,	 s.c.)	 or	morphine	
(7.5	 mg/kg,	 s.c.).	 On	 the	 test	 day,	 the	 rats	 received	
saline	 (1	ml/kg)	 or	 different	 doses	 of	morphine	 (0.5,	
2.5,	 5.0,	 or	 7.5	 mg/kg,	 s.c.)	 30	 min	 before	 the	 test	
(pretest	 administrations),	 and	 memory	 retrieval	 was	
measured	30	min	later	(Fig.	1).
Experiment 2.	 The	 effects	 of	 pre­test	 intra­CA1 
microinjections	of	betaxolol	on	memory	retrieval	were	
investigated.	 Five	 groups	 of	 animals	 received	 post­
training	 administrations	 of	 saline	 (1	 ml/kg).	 On	 the	
test	 day,	 they	 received	 different	 pretest	 small	 intra­
CA1	 doses	 of	 betaxolol	 (0.0,	 0.0625,	 0.125,	 0.25,	 or	
0.5	µg	per	rat)	30	min	before	retrieval	testing	(Fig.	2).
Experiment 3.	 The	 effects	 of	 pre­test	 intra­CA1 
microinjections	 of	 betaxolol	 on	 morphine­modified	
state-dependent memory were investigated in 
experiment	3.	Four	groups	of	animals	were	used	in	this	
experiment.	 All	 groups	 of	 rats	 received	 post­training	
administrations	 of	 morphine	 (7.5	 mg/kg,	 s.c.).	 Then,	
these groups received intra-CA1	 microinjections	 of	
different	 doses	 of	 betaxolol	 (0.0,	 0.0625,	 0.125,	 or	 
0.25	 µg	 per	 rat)	 plus	 morphine	 (7.5	 mg/kg)	 30	 min	
before	 testing	 on	 the	 test	 day	 (Fig.	 3).	 It	 is	 important	
to	 note	 that	 the	 interval	 between	 two	 injections	 was	 
5	min	long.	
After	 behavioral	 testing,	 animals	 were	 euthanized	
and	 microinjected	 with	 1%	 methylene	 blue	 into	 the	
CA1	 (0.5	 µl	 per	 side).	 Then	 they	 were	 decapitated;	
their	brains	were	removed	and	placed	in	10%	formalin	
solution.	After	 10	 days,	 the	 brains	 were	 sliced,	 and	
the	 sites	 of	 injections	were	 verified	 according	 to	 the	
rat	brain	atlas	[36].	Data	from	rats	that	received	drugs	
outside the CA1	were	omitted.	
Data Analysis. The	data	are	expressed	as	means	± 
±	 s.e.m.	 Statistical	 processing	 was	 performed	 using	
one­way	 analysis	 of	 variance	 (ANOVA).	 Post­
hoc comparison of the means was carried out with 
the	 Tukey’s	 test	 for	 multiple	 comparisons	 when	
appropriate.	 Intergroup	 differences	 were	 considered	
significant at P	 <	 0.05.	Calculations	were	 performed	
using	SPSS	statistical	software.
RESULTS 
Effect of Morphine on Memory Retrieval. Figure 
1	 shows	 the	 effects	 of	 morphine	 (post­training/pre­
testing	 administrations)	 on	 the	 STLs	 (Fig.	 1A)	 and	
F i g. 1. Effect	of	morphine	on	memory	retrieval.	Vertical	scale:	in	A,	step­through	latencies,	sec;	in	B,	time	spent	in	the	dark	chamber,	sec.	
The	animals	received	post­training	morphine	(7.5	mg/kg,	s.c.)	and	also	pre­testing	saline	(1	ml/kg	s.c.,	Contr.)	or	morphine	(2.5,	5.0,	and	 
7.5	mg/kg,	s.c.,	1­3,	respectively).	The	columns	show	means	±	s.e.m.	(n	=	8).	*P <	0.05,	and	**P <	0.01,	compared	to	the	control	group	
(Contr.,	morphine,	7.5	mg/kg,	s.c.,	and	saline,	1.0	ml/kg,	s.c.).
Р и с. 1. Вплив	морфіну	на	збереження	пам’ятних	слідів.
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total	TSD	(B).	Statistical	analysis	by	one­way	ANOVA	
showed	 that,	 in	 animals	 with	 impaired	 retrieval	
due to post-training administration of morphine 
(7.5	mg/kg),	pre­test	administration	of	morphine	(2.5,	
5.0,	 and	 7.5	 mg/kg,	 s.c.)	 restored	 the	 retrieval.	 The	
effect	of	morphine	was	manifested	in	the	increased	STLs	 
[F	 (3,	 28)	 =	 7.033,	P	 =	 0.0011]	 and	 decreased	 TSD	 
[F	 (3,	 28)	 =	 5.48,	 P	 <	 0.0043],	 as	 compared	 with	
the	 control	 values.	 This	 phenomenon	 is	 well	
known	 as	 morphine­induced	 (morphine­modified)	
state­dependent	 memory	 retrieval.	 The	 maximum	
restoration	was	observed	with	the	maximum	used	dose	
of	morphine	(7.5	mg/kg;	P <	0.01).	
Effect of Intra-CA1 Microinjection of Betaxolol 
on Memory Retrieval. Figure	 2	 shows	 the	 effects	
of	 pre­test	microinjections	 of	 betaxolol	 on	 the	 STLs	 
(Fig.	 2A)	 and	 total	 TSD	 (B).	 Statistical	 analysis	 by	
one­way	 ANOVA	 showed	 that	 betaxolol	 (0.0625,	
0.125,	 0.25,	 and	 0.5	 µg	 per	 rat)	 decreased	 the	 STLs	 
[F	 (4,	 35)	 =	 4.99,	 P	 =	 0.0047]	 in	 a	 dose­dependent	
manner	 and	 increased	 the	 TSD	 [F(4,	 35)	 =	 4.033,	 
P	 =	 0.0098)],	 as	 compared	 with	 the	 control	 values.	
F i g. 2.	Effect	of	betaxolol	on	memory	 retrieval.	All	 animals	 received	post­training	 saline	 (1.0	ml/kg,	 s.c.)	 and	also	pre­testing	 saline 
(1.0	ml	per	rat)	or	betaxolol	(0.0625,	0.125,	0.25,	and	0.5	mg	per	rat,	1­4,	respectively).	The columns	show	means	±	s.e.m.	(n	=	8).	*P	<	0.05,	
compared	to	the	control	saline	group	(Contr.).	Other	designations	are	the	same	as	in	Fig.	1.
Р и с. 2.	Вплив	бетаксололу	на	збереження	пам’ятних	слідів.
F i g. 3. Effect	of	betaxolol	on	memory	retrieval.	All	animals	received	post­training	morphine	(7.5	mg/kg,	s.c.)	and	also	pre­testing	low	
doses	of	betaxolol	(0.0625,	0.125,	and	0.25	mg	per	rat,	1­3,	respectively)	plus	morphine	(7.5	mg/kg,	s.c.).	The columns	show	means	±	s.e.m.	
(n	=	8).	*P <	0.05	and	**	P <	0.01,	compared	to	the	control	group	(Contr.,	saline/betaxolol).
Р и с. 3.	Вплив	бетаксололу	на	збереження	пам’ятних	слідів,	модифіковане	під	дією	морфіну.
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These	 observations	 are	 indicative	 of	 memory	
retrieval	 impairment.	 The	 Tukey’s	 test	 showed	 that	
the	maximum	modification	was	obtained	with	0.5	µg	
betaxolol	per	rat	(P	<	0.01).		
Effect of Pretest Intra-CA1 Microinjection of 
Betaxolol in the Presence of Morphine on Memory 
Retrieval. Figure	 3	 shows	 the	 effect	 of	 pre­test	
intra-CA1	 administration	 of	 betaxolol	 on	 morphine­
modified	state­dependent	memory	retrieval.	One­way	
ANOVA	 indicated	 that	 animals	 that	 received	 post­
training and pre-test administrations of morphine 
(7.5	mg/kg)	 and	pre­test	 intra­CA1 administrations of 
low	 doses	 of	 betaxolol	 (0.0625,	 0.125,	 and	 0.25	 µg	
per	 rat)	 demonstrated	 dose­dependent	 decreases	 in	
the	STLs	 [F	 (3,	28)	=	4.79,	P	=	0.0081,	Fig.	1A]	and	
increases	in	the	TSD	[F	(3,	28)	=	4.189,	P	=	0.0156,	B).	
DISCUSSION
In	 our	 study,	 the	 role	 of	 b1­adrenergic	 receptors	
of CA1 of the dorsal hippocampus in morphine-
modified	state­dependent	memory	has	been	evaluated	
by	 using	 the	 step­through	 passive	 avoidance	 model.	
According	to	our	own	results,	which	are	in	agreement	
with	 previous	 reports	 [3,	 9],	 post­training	 systemic	
morphine administration dose-dependently decreased 
retrieval in the passive avoidance task  on the test 
day	 and,	 thus,	 induced	 amnesia.	 Furthermore,	 the	
memory	retrieval	impairment	induced	by	post­training	
administration	 of	 morphine	 was	 reversed	 by	 pre­
test	 morphine	 administration,	 also	 dose­dependently.	
These	data,	in	agreement	with	other	previous	studies,	
indicate that morphine effectively modifies state-
dependent	 memory	 [37,	 38].	 Considering	 that	
injection	of	naloxone	decreases	the	effect	of	morphine	
on	 memory	 [39],	 it	 seems	 that	 m-opioid receptors 
mediate	 this	 phenomenon.	 Although	 several	 studies	
indicated that different central neurotransmitter 
systems are involved in the effect of morphine on 
memory	 retrieval,	 precisely	 the	 participation	 of	 the	
hippocampus	is	important	for	this	effect.	
Our experiments also showed that the pre-test 
microinjection	 of	 betaxolol,	 a	 selective	 antagonist	
of b1­adrenergic	 receptor,	 into	 the	 CA1 dose-
dependently	reduces	memory	retrieval.	These	data	are	
in	 agreement	with	 previous	 communications.	 Studies	
using adrenergic agents indicated that adrenergic 
receptors play a rather important role in the memory 
processes.	 The	 enhancement	 of	 memory	 retrieval	
due to peripherally and centrally administered 
adrenoreceptor	agonists	can	be	suppressed	by	different	
antagonists	 of	 these	 receptors.	 Propranolol	 and	
timolol	 (i.e.,	b­adrenergic	 receptor	 antagonists)	 have	
been	 shown	 to	 decrease	 the	 level	 of	 acquisition	 of	
various	models	of	memory	in	rats.	On	the	other	hand,	
b­adrenergic	 agonists,	 including	 isoprenaline	 and	
clenbuterol,	 increased	 retrieval	 of	 memory	 retention	 
[12,	17,	18,	40].	
It seems that activation of b­adrenergic	receptors	by	
isoproterenol	 (an	 agonist)	 increases	 calcium	 currents	
and	facilitates	synaptic	transmission,	i.e.,	phenomena	
needed	 for	 the	 memory	 processes.	 In	 addition,	
activation of b-adrenergic receptors up-regulate 
cAMP­linked	intracellular	signaling	pathways	[41­43]	
maintaining	synaptic	transmission.	
In	 the	basolateral	nuclei	of	 the	amygdala,	 synaptic	
facilitation	 is	 mediated	 by	 activation	 of	 both	 b1­	
and b2­adrenergic	 receptors	 [43].	 The	 basolateral	
amygdala modulates memory formation via activation 
of	 these	 subtypes	 of	 b­adrenoreceptors	 [43­45]. 
Although	it	was	reported	that	pre­test	intra­amygdalar	
microinjections	 of	 low	 doses	 of	 a	 b1­adrenergic	
receptor	antagonist,	atenolol,	did	not	alter	retrieval	in	
the	passive	avoidance	memory	test	[46],	other	studies	
showed	 that	 the	 blockade	 of	 b1­receptors	 in	 the	
basolateral	 amygdala	 impaired	 auditory	 fear	memory	
[47].	 Xamoterol,	 a	 b1­adrenergic	 receptor	 agonist,	
effectively increased the retrieval in the contextual 
fear	 memory	 test.	 This	 response	 was	 reversed	 by	
betaxolol	administrations	[48].
Our	 results	 revealed	 that	 blocking	 of	 b1­
adrenergic receptors in the CA1	 by	 pre­test	 intra­
CA1	 microinjections	 of	 ineffective	 low	 doses	 of	
betaxolol	 (which	 did	 not	 affect	 memory	 retrieval	
per se)	 disrupted	 retrieval	 in	 the	 morphine	 state­
dependent	 memory	 tests.	 Some	 studies	 showed	
that noradrenergic receptors are involved in state-
dependent	 memory	 [49,	 50].	 For	 example,	 it	 was	
shown that the dorsal hippocampal a-adrenergic 
system modulates retrieval in scopolamine-modulated 
state­dependent	memory	[51].	It	was	also	reported	that	
drug­related	memories	can	be	attenuated	by	injections	
of	propranolol	[52].	Interactions	between	b-adrenergic 
receptors	and	opioidergic	systems	in	behavioral	tests,	
including such effects as corticosterone release in 
morphine­dependent	 rats	 [53],	 morphine­conditioned	
place	 preference	 memory	 retrieval	 in	 mice	 [54],	
and memory consolidation and opiate withdrawal 
[55],	 were	 reported	 in	 a	 number	 of	 publications.	 On	
the	 other	 hand,	 b-adrenergic receptor activation has 
been	 known	 to	 play	 an	 important	 role	 in	 memory­
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related	 processes	 in	 the	 hippocampus	 [28,	 30].	 The	
blockade	 of	 b-adrenergic receptors in the CA1 area 
of	 the	 hippocampus	 impairs	 memory	 formation	 by	
attenuating	 the	 activity	 of	 the	 cAMP­PKA­CREB	
intracellular	pathway	[56].
In	conclusion,	our	observations	support	the	statement	
that the CA1 region of the dorsal hippocampus is a 
target area for morphine-modified state-dependent 
memory.	It	seems	that	the	role	of	the	CA1 in mediating 
this	effect	of	morphine	may	be	partly	due	to	activation	
of b1­adrenergic	 receptors	 in	 this	area.	The	blockade	
of CA1 b1­adrenergic	 receptors	 prevents	 morphine­
induced	 modulation	 of	 state­dependent	 memory.	
The involvement of these receptors in this effect of 
morphine	may	be	mediated,	directly	or	indirectly,	via	
other	 neurotransmitter­related	 mechanisms,	 such	 as	
acetylcholinergic,	 glutamatergic,	 and	 dopaminergic	
ones.			
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Р	е	з	ю	м	е
У	нашій	роботі	ми	досліджували	впливи	мікроін’єкцій	се-
лективного	антагоніста	b1­адренорецепторів	бетаксололу	в	
ділянку	 	CA1	 гіпокампа	на	формування	залежної	від	стану	
пам’яті,	індукованої	ін’єкціями	морфіну.		Для	оцінки	ефек-
тивності	 здобування	 пам’ятних	 слідів	 використовували	
тест	 пасивного	 уникання.	Самцям	щурів	 лінії	Вістар	 	 сте-
реотаксично	 імплантували	 канюлі	 в	 ділянку	CA1	 дорсаль-
ного	 гіпокампа	 за	 сім	 днів	 до	 тренування.	 Кожну	 тварину	
тестували	 через	 24	 год	 після	 тренування	 з	 вимірюванням	
латентного	 періоду	 уникання	 та	 тривалості	 перебування	 у	
темному	відсіку	тест­установки.	Підшкірне	введення	5	або	
7.5	 мг/кг	 морфіну	 після	 тренування	 послаблювало	 збере-
ження	 пам’ятних	 слідів	 у	 відповідному	 тесті	 (індукована	
морфіном	амнезія).	Ефекти	ін’єкцій	7.5	мг/кг	морфіну	піс-
ля	тренувань	спотворювалися	внаслідок	ін’єкцій	морфіну	в	
тій	 самій	дозі,	 виконаних	перед	тестом.	Цей	феномен	ква-
ліфікується	 як	модифікація	 залежної	 від	 стану	пам’яті	під	
впливом	морфіну.	Як	показали	результати	наших	дослідів,	
мікроін’єкції	в	ділянку	CA1	малих	(неефективних)	кількос-
тей	 бетаксололу	 (0.125	 або	 0.25	 мкг	 на	 тварину)	 послаб­
лювали	 збереження	 індукованих	 морфіном	 модифікацій	
залежної	від	стану	пам’яті.	У	цілому	наші	результати	доз­
воляють	вважати,	що	ділянка	CA1	є	критичною	для	форму-
вання	модифікованої	морфіном	 залежної	 від	 стану	пам’яті	
і	що	b1­адренергічні	 рецепторні	механізми	 взаємодіють	 із	
опіоїдергічною	системою	в	перебігу	модуляції	пам’яті	цьо-
го	типу	у	щурів.	
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